• AMG 487 CXCR3 Antagonist: Assay Workflows

  2026-09-01

  AMG 487 is a potent, selective CXCR3 antagonist for separating chemokine-driven migration, calcium signaling, and macrophage-state effects. This practical guide translates CXCL10-CXCR3 findings into reproducible workflows, with concentration planning, controls, troubleshooting, and limitations for inflammation and cancer biology research.

• Affordable GRO-seq in Bread Wheat: Methods and Findings

  2026-09-01

  This protocol study improves Global Run-On sequencing (GRO-seq) for allohexaploid bread wheat by adding rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation. The workflow increased the proportion of valid sequencing data by 20-fold in enhancer-transcription profiling, offering a practical strategy for reducing sequencing waste in large, complex genomes.

• Eltanexor (KPT-8602): XPO1 Research Guide

  2026-08-31

  Eltanexor, also called KPT-8602, is an orally bioavailable second-generation XPO1 inhibitor for cancer research. Preclinical evidence links XPO1 inhibition with activity in AML, CLL, aggressive lymphoma, and colorectal cancer models, while model-specific conditions limit direct clinical interpretation.

• Cholecystokinin Octapeptide Ammonium: Assay Logic

  2026-08-30

  Cholecystokinin octapeptide ammonium is a sulfated brain–gut peptide with receptor- and context-dependent effects. This guide translates CCK-8 ammonium immunology findings into practical assay design, controls, formulation decisions, and cross-model interpretation.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-29

  The Tricine-SDS-PAGE Gel Preparation Kit is intended for higher-resolution protein electrophoresis and peptide separation in the low-molecular-weight range, where conventional Tris-SDS-PAGE may provide limited separation. It is for scientific research workflows, including denaturing and non-denaturing electrophoresis, and must not be used for diagnostic, clinical, or medical purposes.

• Adipose–Neural Signaling in Cardiac Arrhythmia

  2026-08-29

  Fan et al. developed a stem-cell-based coculture model showing that epicardial adipocyte-derived leptin activates sympathetic neurons, increases neuropeptide Y release, and promotes cardiomyocyte arrhythmia through Y1R, NCX, and CaMKII signaling. The study connects cellular mechanism with atrial fibrillation-associated changes in epicardial adipose tissue and coronary sinus biomarkers, while also defining important boundaries for testing Y2R-directed interventions.

• Veratridine: A Causal Assay Design Guide

  2026-08-28

  Veratridine is a voltage-gated sodium channel opener that converts channel activation into a measurable depolarization and injury phenotype. This guide explains how to separate proximal sodium-channel effects from downstream excitotoxicity, improving neuroscience assays and blocker screens.

• I-BET-762 BET Inhibitor Workflow for Ferroptosis

  2026-08-28

  I-BET-762 is a selective BET inhibitor for connecting bromodomain biology with LPS-driven inflammation and ferroptosis sensitization. This practical guide translates published BRD4 findings into reproducible cell-based workflows, dose controls, readouts, and troubleshooting strategies for cancer biology research and preclinical inflammation studies.

• Kitasamycin for Swine Dysentery: Evidence from Pigs

  2026-08-27

  The reference study evaluated kitasamycin against Australian Brachyspira hyodysenteriae isolates and tested prophylactic and therapeutic dosing in experimentally infected pigs. Its central contribution is the integration of antimicrobial susceptibility testing, 23S rRNA mutation analysis, and a controlled animal challenge, showing that kitasamycin prevented clinical disease when the infecting isolate was susceptible while reducing, but not eliminating, bacterial shedding.

• 5-Azacytidine Workflow for DNA Demethylation

  2026-08-27

  Build reproducible 5-Azacytidine assays that connect DNMT inhibition with gene reactivation, cytotoxicity, and immune-response measurements. This workflow also translates recent PTEN-deficient glioblastoma findings into practical combination and troubleshooting strategies for cancer epigenetics laboratories.

• Tideglusib Targets Pif1 Through Cys-380

  2026-08-26

  Zhou and colleagues identified tideglusib as a small-molecule inhibitor of Bacteroides sp. Pif1, establishing a previously unavailable chemical entry point for studying this conserved helicase family. Orthogonal biochemical assays showed micromolar inhibition, irreversibility, protein aggregation, and dependence on Cys-380, providing a mechanistic framework for future inhibitor development and target validation.

• Verapamil HCl: From Calcium Blockade to Bone

  2026-08-26

  Explore how Verapamil HCl, an L-type calcium channel blocker, can connect calcium signaling with myeloma apoptosis, arthritis inflammation, and Txnip-regulated bone remodeling. This evidence-guided framework focuses on assay selection, mechanistic validation, and translational limitations.

• Huangqin Decoction, AhR, and Intestinal Repair

  2026-08-25

  Li et al. identify a microbiota–tryptophan metabolism–AhR–intestinal stem cell axis through which Huangqin decoction promotes mucosal repair in a dextran sulfate sodium colitis model. The study connects microbial metabolite production with AhR-dependent epithelial differentiation and provides a useful framework for testing causality in ulcerative colitis research.

• Bradykinin BA5201: Practical Vascular Workflow

  2026-08-25

  Bradykinin BA5201 provides a defined research peptide stimulus for endothelial vasodilation, vascular permeability modulation, smooth muscle contraction research, and related inflammation or pain mechanism studies. It is intended only for controlled scientific workflows, not for diagnostic, therapeutic, or other clinical use.

• Wortmannin: PI3K Inhibition in Ferroptosis Research

  2026-08-24

  Wortmannin helps researchers test whether PI3K/AKT activity drives ferroptosis resistance, rather than merely correlating with it. This practical guide connects pathway inhibition with HCC cell models, sorafenib response, apoptosis assay design, and reproducible compound handling.

466 records 7/32 page Previous Next First page 上5页 678910 下5页 Last page